Viewing Study NCT05011851


Ignite Creation Date: 2025-12-24 @ 11:38 PM
Ignite Modification Date: 2026-02-25 @ 9:40 PM
Study NCT ID: NCT05011851
Status: COMPLETED
Last Update Posted: 2025-01-31
First Post: 2021-08-05
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: An Open-Label Study of the Safety, Tolerability, and Pharmacokinetics of Oral NNZ-2591 in Angelman Syndrome
Sponsor: Neuren Pharmaceuticals Limited
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Angelman Syndrome View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Angelman Syndrome View